|
Ivonescimab Combined With Chemotherapy Clinical Trials
2 actively recruiting trials
Pipeline
Phase 2: 1Phase 1/2: 1
Top Sponsors
- Ruijin Hospital1
- Guangdong Provincial People's Hospital1
Indications
- Lung Cancer2
- Cancer2
- KRAS G12C Lung Cancer1
- Malignant Pleural Mesothelioma, Advanced1
- Lung Cancer (NSCLC)1
Other2 trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.